Retinal  ||| S:0 E:8 ||| JJ
nerve  ||| S:8 E:14 ||| NN
fiber  ||| S:14 E:20 ||| NN
thickness  ||| S:20 E:30 ||| NN
and  ||| S:30 E:34 ||| CC
MRI  ||| S:34 E:38 ||| NNP
white  ||| S:38 E:44 ||| JJ
matter  ||| S:44 E:51 ||| NN
abnormalities  ||| S:51 E:65 ||| NN
in  ||| S:65 E:68 ||| IN
healthy  ||| S:68 E:76 ||| JJ
relatives  ||| S:76 E:86 ||| NNS
of  ||| S:86 E:89 ||| IN
multiple  ||| S:89 E:98 ||| JJ
sclerosis  ||| S:98 E:108 ||| NN
patients  ||| S:108 E:117 ||| NNS
To  ||| S:117 E:120 ||| TO
compare  ||| S:120 E:128 ||| VB
retinal  ||| S:128 E:136 ||| JJ
nerve  ||| S:136 E:142 ||| NN
fiber  ||| S:142 E:148 ||| NN
( ||| S:148 E:149 ||| -LRB-
RNFL ||| S:149 E:153 ||| NNP
)  ||| S:153 E:155 ||| -RRB-
thickness  ||| S:155 E:165 ||| NN
and  ||| S:165 E:169 ||| CC
conventional  ||| S:169 E:182 ||| JJ
and  ||| S:182 E:186 ||| CC
non-conventional  ||| S:186 E:203 ||| NNP
MRI  ||| S:203 E:207 ||| NNP
characteristics  ||| S:207 E:223 ||| NNS
of  ||| S:223 E:226 ||| IN
healthy  ||| S:226 E:234 ||| JJ
controls  ||| S:234 E:243 ||| NNS
( ||| S:243 E:244 ||| -LRB-
HCs ||| S:244 E:247 ||| NNP
)  ||| S:247 E:249 ||| -RRB-
from  ||| S:249 E:254 ||| IN
the  ||| S:254 E:258 ||| DT
general  ||| S:258 E:266 ||| JJ
population  ||| S:266 E:277 ||| NN
( ||| S:277 E:278 ||| -LRB-
non-fHC ||| S:278 E:285 ||| NNP
)  ||| S:285 E:287 ||| -RRB-
to  ||| S:287 E:290 ||| TO
healthy  ||| S:290 E:298 ||| JJ
relatives  ||| S:298 E:308 ||| NNS
of  ||| S:308 E:311 ||| IN
multiple  ||| S:311 E:320 ||| JJ
sclerosis  ||| S:320 E:330 ||| NNS
( ||| S:330 E:331 ||| -LRB-
MS ||| S:331 E:333 ||| NNP
)  ||| S:333 E:335 ||| -RRB-
patients  ||| S:335 E:344 ||| NNS
( ||| S:344 E:345 ||| -LRB-
fHC ||| S:345 E:348 ||| NNP
) ||| S:348 E:349 ||| -RRB-
.  ||| S:349 E:351 ||| .
Sixty-eight  ||| S:351 E:363 ||| NNP
( ||| S:363 E:364 ||| -LRB-
68 ||| S:364 E:366 ||| CD
)  ||| S:366 E:368 ||| -RRB-
HCs  ||| S:368 E:372 ||| FW
underwent  ||| S:372 E:382 ||| FW
optical  ||| S:382 E:390 ||| FW
coherence  ||| S:390 E:400 ||| FW
tomography  ||| S:400 E:411 ||| FW
( ||| S:411 E:412 ||| -LRB-
OCT ||| S:412 E:415 ||| NNP
)  ||| S:415 E:417 ||| -RRB-
and  ||| S:417 E:421 ||| CC
3T  ||| S:421 E:424 ||| NNP
MRI  ||| S:424 E:428 ||| NNP
examination ||| S:428 E:439 ||| NN
.  ||| S:439 E:441 ||| .
Subjects  ||| S:441 E:450 ||| NNS
were  ||| S:450 E:455 ||| VBD
classified  ||| S:455 E:466 ||| VBN
based  ||| S:466 E:472 ||| VBN
on  ||| S:472 E:475 ||| IN
whether  ||| S:475 E:483 ||| IN
or  ||| S:483 E:486 ||| CC
not  ||| S:486 E:490 ||| RB
there  ||| S:490 E:496 ||| EX
was  ||| S:496 E:500 ||| VBD
a  ||| S:500 E:502 ||| DT
family  ||| S:502 E:509 ||| NN
history  ||| S:509 E:517 ||| NN
of  ||| S:517 E:520 ||| IN
MS ||| S:520 E:522 ||| NNP
.  ||| S:522 E:524 ||| .
The  ||| S:524 E:528 ||| DT
study  ||| S:528 E:534 ||| NN
enrolled  ||| S:534 E:543 ||| VBD
40  ||| S:543 E:546 ||| CD
non-fHC  ||| S:546 E:554 ||| NNS
who  ||| S:554 E:558 ||| WP
had  ||| S:558 E:562 ||| VBD
no  ||| S:562 E:565 ||| DT
relatives  ||| S:565 E:575 ||| NNS
with  ||| S:575 E:580 ||| IN
MS  ||| S:580 E:583 ||| NNP
and  ||| S:583 E:587 ||| CC
28  ||| S:587 E:590 ||| CD
fHC  ||| S:590 E:594 ||| NN
with  ||| S:594 E:599 ||| IN
at  ||| S:599 E:602 ||| IN
least  ||| S:602 E:608 ||| JJS
one  ||| S:608 E:612 ||| CD
relative  ||| S:612 E:621 ||| JJ
affected  ||| S:621 E:630 ||| VBN
with  ||| S:630 E:635 ||| IN
MS ||| S:635 E:637 ||| NNP
.  ||| S:637 E:639 ||| .
The  ||| S:639 E:643 ||| DT
associations  ||| S:643 E:656 ||| NNS
between  ||| S:656 E:664 ||| IN
OCT  ||| S:664 E:668 ||| NNP
parameters  ||| S:668 E:679 ||| NNS
and  ||| S:679 E:683 ||| CC
conventional  ||| S:683 E:696 ||| JJ
and  ||| S:696 E:700 ||| CC
non-conventional  ||| S:700 E:717 ||| NNP
MRI  ||| S:717 E:721 ||| NNP
measures  ||| S:721 E:730 ||| NNS
were  ||| S:730 E:735 ||| VBD
investigated ||| S:735 E:747 ||| VBN
.  ||| S:747 E:749 ||| .
There  ||| S:749 E:755 ||| EX
were  ||| S:755 E:760 ||| VBD
no  ||| S:760 E:763 ||| DT
significant  ||| S:763 E:775 ||| JJ
OCT  ||| S:775 E:779 ||| NNP
or  ||| S:779 E:782 ||| CC
conventional  ||| S:782 E:795 ||| JJ
and  ||| S:795 E:799 ||| CC
non-conventional  ||| S:799 E:816 ||| NNP
MRI  ||| S:816 E:820 ||| NNP
measureable  ||| S:820 E:832 ||| NN
differences  ||| S:832 E:844 ||| NNS
between  ||| S:844 E:852 ||| IN
the  ||| S:852 E:856 ||| DT
non-fHC  ||| S:856 E:864 ||| JJ
and  ||| S:864 E:868 ||| CC
fHC  ||| S:868 E:872 ||| JJ
groups ||| S:872 E:878 ||| NNS
.  ||| S:878 E:880 ||| .
Periventricular  ||| S:880 E:896 ||| JJ
localization  ||| S:896 E:909 ||| NN
and  ||| S:909 E:913 ||| CC
total  ||| S:913 E:919 ||| JJ
volume  ||| S:919 E:926 ||| NN
of  ||| S:926 E:929 ||| IN
white  ||| S:929 E:935 ||| JJ
matter  ||| S:935 E:942 ||| NN
( ||| S:942 E:943 ||| -LRB-
WM ||| S:943 E:945 ||| NNP
)  ||| S:945 E:947 ||| -RRB-
signal  ||| S:947 E:954 ||| NN
abnormalities  ||| S:954 E:968 ||| NNS
( ||| S:968 E:969 ||| -LRB-
SA ||| S:969 E:971 ||| NNP
)  ||| S:971 E:973 ||| -RRB-
were  ||| S:973 E:978 ||| VBD
more  ||| S:978 E:983 ||| RBR
common  ||| S:983 E:990 ||| JJ
in  ||| S:990 E:993 ||| IN
the  ||| S:993 E:997 ||| DT
fHC  ||| S:997 E:1001 ||| JJ
group  ||| S:1001 E:1007 ||| NN
but  ||| S:1007 E:1011 ||| CC
the  ||| S:1011 E:1015 ||| DT
differences  ||| S:1015 E:1027 ||| NNS
did  ||| S:1027 E:1031 ||| VBD
not  ||| S:1031 E:1035 ||| RB
reach  ||| S:1035 E:1041 ||| VB
a  ||| S:1041 E:1043 ||| DT
level  ||| S:1043 E:1049 ||| NN
of  ||| S:1049 E:1052 ||| IN
significance ||| S:1052 E:1064 ||| NN
.  ||| S:1064 E:1066 ||| .
A  ||| S:1066 E:1068 ||| DT
significant  ||| S:1068 E:1080 ||| JJ
association  ||| S:1080 E:1092 ||| NN
between  ||| S:1092 E:1100 ||| IN
decreased  ||| S:1100 E:1110 ||| JJ
RNFL  ||| S:1110 E:1115 ||| NNP
thickness  ||| S:1115 E:1125 ||| NN
with  ||| S:1125 E:1130 ||| IN
increased  ||| S:1130 E:1140 ||| JJ
volume  ||| S:1140 E:1147 ||| NN
( ||| S:1147 E:1148 ||| -LRB-
p=0.001 ||| S:1148 E:1155 ||| NNP
) ||| S:1155 E:1156 ||| -RRB-
,  ||| S:1156 E:1158 ||| ,
number  ||| S:1158 E:1165 ||| NN
( ||| S:1165 E:1166 ||| -LRB-
p=0.003 ||| S:1166 E:1173 ||| NNP
)  ||| S:1173 E:1175 ||| -RRB-
and  ||| S:1175 E:1179 ||| CC
frequency  ||| S:1179 E:1189 ||| NN
of  ||| S:1189 E:1192 ||| IN
â‰¥  ||| S:1192 E:1194 ||| CD
9  ||| S:1194 E:1196 ||| CD
T2  ||| S:1196 E:1199 ||| CD
( ||| S:1199 E:1200 ||| -LRB-
p=0.003 ||| S:1200 E:1207 ||| NNP
)  ||| S:1207 E:1209 ||| -RRB-
WM  ||| S:1209 E:1212 ||| NNP
SAs  ||| S:1212 E:1216 ||| NNP
on  ||| S:1216 E:1219 ||| IN
MRI  ||| S:1219 E:1223 ||| NNP
was  ||| S:1223 E:1227 ||| VBD
found  ||| S:1227 E:1233 ||| VBN
in  ||| S:1233 E:1236 ||| IN
the  ||| S:1236 E:1240 ||| DT
fHC  ||| S:1240 E:1244 ||| JJ
group ||| S:1244 E:1249 ||| NN
.  ||| S:1249 E:1251 ||| .
No  ||| S:1251 E:1254 ||| DT
association  ||| S:1254 E:1266 ||| NN
between  ||| S:1266 E:1274 ||| IN
OCT  ||| S:1274 E:1278 ||| NNP
and  ||| S:1278 E:1282 ||| CC
MRI  ||| S:1282 E:1286 ||| NNP
parameters  ||| S:1286 E:1297 ||| NNS
was  ||| S:1297 E:1301 ||| VBD
detected  ||| S:1301 E:1310 ||| VBN
in  ||| S:1310 E:1313 ||| IN
the  ||| S:1313 E:1317 ||| DT
non-fHC  ||| S:1317 E:1325 ||| JJ
group ||| S:1325 E:1330 ||| NN
.  ||| S:1330 E:1332 ||| .
There  ||| S:1332 E:1338 ||| EX
is  ||| S:1338 E:1341 ||| VBZ
an  ||| S:1341 E:1344 ||| DT
association  ||| S:1344 E:1356 ||| NN
between  ||| S:1356 E:1364 ||| IN
decreased  ||| S:1364 E:1374 ||| JJ
RNFL  ||| S:1374 E:1379 ||| NNP
thickness  ||| S:1379 E:1389 ||| NN
on  ||| S:1389 E:1392 ||| IN
OCT  ||| S:1392 E:1396 ||| NNP
and  ||| S:1396 E:1400 ||| CC
increased  ||| S:1400 E:1410 ||| VBD
WM  ||| S:1410 E:1413 ||| NNP
injury  ||| S:1413 E:1420 ||| NN
in  ||| S:1420 E:1423 ||| IN
healthy  ||| S:1423 E:1431 ||| JJ
relatives  ||| S:1431 E:1441 ||| NNS
of  ||| S:1441 E:1444 ||| IN
MS  ||| S:1444 E:1447 ||| NNP
patients ||| S:1447 E:1455 ||| NNS
.  ||| S:1455 E:1457 ||| .
Further  ||| S:1457 E:1465 ||| JJ
studies  ||| S:1465 E:1473 ||| NNS
should  ||| S:1473 E:1480 ||| MD
explore  ||| S:1480 E:1488 ||| VB
the  ||| S:1488 E:1492 ||| DT
pathophysiology  ||| S:1492 E:1508 ||| NN
of  ||| S:1508 E:1511 ||| IN
these  ||| S:1511 E:1517 ||| DT
findings ||| S:1517 E:1525 ||| NNS
.  ||| S:1525 E:1527 ||| .
